Clinicians are reminded to include non-prescription supplement history when evaluating thrombotic events in younger adults ...

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update First Commercial Sales of REDEMPLO® ...

A PFAS-remediation project using sustainably manufactured granulated activated carbon for drinking water demonstrates how ...

Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...

The company plans to ready an update in time for a February earnings call with investors. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

This article was reviewed by Felix Gussone, MD. Key Takeaways: Preparing properly for lab tests helps ensure your results are accurate and reliable. Some tests — … ...

“Bad,” or LDL, cholesterol is a major risk factor for heart disease and most people are screened for it as part of their yearly physicals ...

The test integrates the measurements of five proteins to assess if patients have the brain pathology characteristic of Alzheimer's disease.